Sándor T, László E, Magyary F, Turcsányi G, Hetényi L, Izinger E
Acta Chir Hung. 1986;27(2):107-14.
The effect and the degree of safety of administering a fixed combination of 5000 IU of heparin + 0.5 mg dihydroergotamine (HDHE s.c. per every 12 hours) as opposed to 5000 IU of heparin (LDH s.c. every 8 hours) was assessed in a prospective randomized study on 86 patients having undergone major abdominal operation. Postoperatively a deep vein thrombosis was detected by the radiofibrinogen test in 10% of the 40 patients of the HDHE group and in 13% of 46 of the LDH group. Four patients died. At autopsy neither fatal nor a contributing pulmonary embolism was found. 'Non-lethal' pulmonary embolism diagnosed by lung perfusion scintigraphy and by chest X-rays, developed in 2 patients treated with LDH and in one treated with HDHE. Two-thirds of the dose of heparin were identically effective in prevention of venous thromboembolisms than the whole dose if heparin was combined with DHE. The decrease of the heparin dose significantly reduced the number of wound haematomas and of suffusion due to injection.
在一项针对86例接受腹部大手术患者的前瞻性随机研究中,评估了每12小时皮下注射5000国际单位肝素+0.5毫克双氢麦角胺(HDHE)的固定组合与每8小时皮下注射5000国际单位肝素(LDH)相比的效果和安全程度。术后,通过放射性纤维蛋白原试验在HDHE组的40例患者中的10%以及LDH组的46例患者中的13%检测到深静脉血栓形成。4例患者死亡。尸检未发现致命性或导致死亡的肺栓塞。通过肺灌注闪烁扫描和胸部X线诊断的“非致命性”肺栓塞在2例接受LDH治疗的患者和1例接受HDHE治疗的患者中出现。如果肝素与双氢麦角胺联合使用,三分之二剂量的肝素在预防静脉血栓栓塞方面与全剂量肝素同样有效。肝素剂量的减少显著降低了伤口血肿和注射所致渗血的数量。